Novavax (NVAX) News Today $8.06 +0.06 (+0.75%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period B. Riley Has Bearish Forecast for Novavax FY2024 EarningsNovember 21 at 1:15 AM | americanbankingnews.comNovavax, Inc. (NVAX) Jefferies London Healthcare Conference (Transcript)November 20 at 2:02 PM | seekingalpha.comWhat is B. Riley's Forecast for Novavax FY2024 Earnings?Novavax, Inc. (NASDAQ:NVAX - Free Report) - Investment analysts at B. Riley reduced their FY2024 EPS estimates for shares of Novavax in a research report issued to clients and investors on Monday, November 18th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will pNovember 20 at 6:24 AM | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAXNovember 18 at 9:12 PM | prnewswire.comStrategic Transformation and Growth Prospects: Mayank Mamtani’s Buy Rating on NovavaxNovember 18 at 4:05 PM | markets.businessinsider.comFY2024 Earnings Estimate for Novavax Issued By HC WainwrightNovavax, Inc. (NASDAQ:NVAX - Free Report) - HC Wainwright lowered their FY2024 earnings per share (EPS) estimates for Novavax in a research report issued on Wednesday, November 13th. HC Wainwright analyst V. Bernardino now expects that the biopharmaceutical company will earn ($1.29) per share forNovember 18 at 1:49 AM | marketbeat.comNovavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target PriceNovember 16, 2024 | finance.yahoo.comNovavax Inc. stock underperforms Friday when compared to competitors despite daily gainsNovember 16, 2024 | marketwatch.comNovavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)November 15, 2024 | prnewswire.comResearch Analysts Offer Predictions for Novavax Q3 EarningsNovember 15, 2024 | americanbankingnews.comBiotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study DataNovember 14, 2024 | finance.yahoo.comNovavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...November 14, 2024 | finance.yahoo.comNovavax: Balancing Potential and Risk Amid Strategic Shifts and Uncertain Market OutlookNovember 14, 2024 | markets.businessinsider.comWhat is HC Wainwright's Estimate for Novavax Q3 Earnings?Novavax, Inc. (NASDAQ:NVAX - Free Report) - Investment analysts at HC Wainwright issued their Q3 2024 earnings per share estimates for Novavax in a research note issued on Tuesday, November 12th. HC Wainwright analyst V. Bernardino expects that the biopharmaceutical company will earn ($0.64) perNovember 14, 2024 | marketbeat.comNovavax: Stock plunges after quarterly earnings, but sees hope in licensing dealsNovember 14, 2024 | msn.comNovavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock FallsNovember 14, 2024 | finance.yahoo.comNovavax falls after guidance cut on lower vaccine salesNovember 14, 2024 | msn.comNovavax price target lowered to $9 from $14 at TD CowenNovember 14, 2024 | markets.businessinsider.comNovavax’s Market Share and Pipeline Uncertainties Lead to Sell RatingNovember 14, 2024 | markets.businessinsider.comNovavax price target lowered to $12 from $14 at BofANovember 14, 2024 | markets.businessinsider.comNovavax (NASDAQ: NVAX) Successfully Addresses FDA Clinical Hold; Trial ResumesGAITHERSBURG, Md. – Novavax, Inc. (NASDAQ: NVAX) announced on November 11, 2024, that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on Novavax’s November 14, 2024 | americanbankingnews.comNovavax Advances Vaccine Strategy Amid Financial ShiftsNovember 13, 2024 | markets.businessinsider.comNovavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comNovavax (NASDAQ:NVAX) Posts Earnings Results, Beats Expectations By $0.11 EPSNovavax (NASDAQ:NVAX - Get Free Report) announced its earnings results on Tuesday. The biopharmaceutical company reported ($0.76) EPS for the quarter, topping the consensus estimate of ($0.87) by $0.11. The business had revenue of $84.51 million for the quarter, compared to the consensus estimate of $65.80 million. During the same period in the prior year, the business posted ($1.26) earnings per share. The firm's revenue for the quarter was down 54.8% compared to the same quarter last year.November 13, 2024 | marketbeat.comNovavax Q3 Earnings Disappoint, But A Turnaround May Be UnderwayNovember 13, 2024 | seekingalpha.comNovavax to Participate in Jefferies London Healthcare ConferenceNovember 13, 2024 | prnewswire.comNovavax, Inc. (NVAX) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comNovavax Stock is Slipping After the Vaccine Maker Cut its Outlook AgainNovember 12, 2024 | investopedia.comNovavax, Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 12, 2024 | seekingalpha.comNovavax Stock Dives Even Though Results Beat ForecastsNovember 12, 2024 | barrons.comNovavax's (NVAX) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $19.00 price objective on shares of Novavax in a research report on Tuesday.November 12, 2024 | marketbeat.comNovavax cuts 2024 revenue forecast again on lower COVID vaccine salesNovember 12, 2024 | reuters.comNovavax Reports Third Quarter 2024 Financial Results and Operational HighlightsNovember 12, 2024 | prnewswire.comInvestors Purchase High Volume of Novavax Call Options (NASDAQ:NVAX)November 12, 2024 | americanbankingnews.comNovavax Gets FDA Approval To Resume Testing Two Vaccines After Clinical HoldNovember 11, 2024 | investopedia.comNovavax (NASDAQ:NVAX) Shares Gap Up - Should You Buy?Novavax (NASDAQ:NVAX) Shares Gap Up - What's Next?November 11, 2024 | marketbeat.comNovavax Target of Unusually High Options Trading (NASDAQ:NVAX)Novavax, Inc. (NASDAQ:NVAX - Get Free Report) was the recipient of some unusual options trading on Monday. Stock investors acquired 25,185 call options on the company. This represents an increase of approximately 6% compared to the average daily volume of 23,679 call options.November 11, 2024 | marketbeat.comUS FDA lifts clinical hold on Novavax's combo COVID-flu shotNovember 11, 2024 | reuters.comU.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 TrialNovember 11, 2024 | prnewswire.comNovavax (NVAX) Set to Announce Earnings on TuesdayNovember 11, 2024 | americanbankingnews.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAXNovember 10, 2024 | prnewswire.comNovavax Settles Vaccine Supply Agreement DisputeNovember 7, 2024 | markets.businessinsider.comWhy Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?November 7, 2024 | finance.yahoo.comNovavax, UK terminate vaccine supply agreementNovember 5, 2024 | reuters.comNovavax (NVAX) Scheduled to Post Quarterly Earnings on TuesdayNovavax (NASDAQ:NVAX) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports.November 5, 2024 | marketbeat.comNovavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024November 4, 2024 | prnewswire.comNovavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from AnalystsNovavax, Inc. (NASDAQ:NVAX - Get Free Report) has been assigned an average recommendation of "Hold" from the six analysts that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three hNovember 4, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAXNovember 2, 2024 | prnewswire.comNovavax Q3 Earnings A Week Away - Time To Accept A New RealityOctober 31, 2024 | seekingalpha.comModerna, Pfizer or Novavax? How the three Covid-19 vaccines differ according to Yale MedicineOctober 30, 2024 | yahoo.com Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin NVAX Media Mentions By Week NVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVAX News Sentiment▼0.200.45▲Average Medical News Sentiment NVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVAX Articles This Week▼2610▲NVAX Articles Average Week Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Relay Therapeutics News Adaptive Biotechnologies News Kodiak Sciences News Twist Bioscience News Iovance Biotherapeutics News Denali Therapeutics News CRISPR Therapeutics News Alkermes News Amicus Therapeutics News Geron News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVAX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVAX Stock Alerts